Hajime Izumiyama: Influence Statistics

Hajime Izumiyama

Hajime Izumiyama

Center for Medical Welfare and Liaison Services, Tokyo Medical and Dental University, Bunkyo-ku, Tokyo 113-8510, Japan. | Department of Molecular Endocrinology and Metabolism, ...

Hajime Izumiyama: Expert Impact

Concepts for which Hajime Izumiyama has direct influence: Type 2 diabetes , Type 2 , Periodontal treatment , Endothelial dysfunction , Insulin treatment , Visceral fat , Visceral adiposity .

Hajime Izumiyama: KOL impact

Concepts related to the work of other authors for which for which Hajime Izumiyama has influence: Type 2 diabetes , Primary aldosteronism , Periodontal treatment , Glycemic control , Cushing syndrome , Arterial stiffness , Muscle mass .

KOL Resume for Hajime Izumiyama

Year
2019

Center for Medical Welfare and Liaison Services, Tokyo Medical and Dental University, Bunkyo-ku, Tokyo 113-8510, Japan.

2018

Department of Molecular Endocrinology and Metabolism, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Tokyo 113-8510, Japan.

2017

Center for Medical Welfare and Liaison Services, Tokyo Medical and Dental University

2016

Center for Medical Welfare and Liaison Services, Tokyo Medical and Dental University, 1-5-45 Yushima, Bunkyo-ku, Tokyo, 113-8510 Japan

2015

Department of Molecular Endocrinology and MetabolismGraduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, 1-5-45 Yushima, Bunkyo-ku, Tokyo 113-8510, JapanDepartment of Maternal-Fetal BiologyNational Research Institute for Child Health and Development, Tokyo 157-8535, JapanCenter for Medical Welfare and Liaison ServicesDepartments of UrologyPreemptive Medicine and MetabolismOrgan Network and MetabolismGraduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Tokyo 113-8510, JapanJapan Science and Technology AgencyPRESTO, Tokyo 102-0076, JapanJapan Science and Technology AgencyCREST, Tokyo 102-0076, Japan Department of Molecular Endocrinology and MetabolismGraduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, 1-5-45 Yushima, Bunkyo-ku, Tokyo 113-8510, JapanDepartment of Maternal-Fetal BiologyNational Research Institute for Child Health and Development, Tokyo 157-8535, JapanCenter for Medical Welfare and Liaison ServicesDepartments of UrologyPreemptive Medicine and MetabolismOrgan Network and MetabolismGraduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Tokyo 113-8510, JapanJapan Science and Technology AgencyPRESTO, Tokyo 102-0076, JapanJapan Science and Technology AgencyCREST, Tokyo 102-0076, Japan.

Center for Medical Welfare and Liaison Services, Tokyo Medical and Dental University, 113-8510, Tokyo, Japan

2013

Tokyo Medical and Dental University Medical Hospital, Tokyo, Japan

2012

Department of Clinical and Molecular Endocrinology, Tokyo Medical and Dental University Graduate School

Tokyo Medical and Dental University Medical Hospital

2011

Department of Clinical and Molecular Endocrinology, Tokyo Medical and Dental University Graduate School, Japan

Clinical and Molecular Endocrinology, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University

2005

Department of Clinical and Molecular Endocrinology Tokyo Medical and Dental University Graduate School

Prominent publications by Hajime Izumiyama

KOL-Index: 14690 . BACKGROUND: Abdominal visceral obesity has been reported to be associated with cardiovascular risks than body mass index, waist circumference, and abdominal subcutaneous fat. On the other hand, there is evidence that subcutaneous fat has a beneficial role against cardio-metabolic risks such as diabetes or dyslipidemia. However, little is known regarding the association between high ...
Known for Visceral Fat | Type 2 Diabetes | Atherosclerosis Patients | Vfa ≥
KOL-Index: 13361 . OBJECTIVE: Differential expression of several genes between ACTH-secreting pituitary tumors causing Cushing' disease (CD), silent corticotroph adenoma (SCA), and non-functioning pituitary tumors (NFT) was investigated. DESIGN AND METHODS: We used tissue specimens from 35 pituitary tumors (12 CD, 8 SCA, and 15 NFT). Steady-state mRNA levels of the genes related to proopiomelanocortin (POMC) ...
Known for Gene Expression | Sca Nft | Messenger Receptors | Functioning Pituitary
KOL-Index: 12038 . BackgroundAccumulation of epicardial fat (EF) is associated with increased cardio-metabolic risks and coronary events, independently of traditional cardiovascular risk factors. Therefore, the reduction of EF volume (EFV) may be associated with reduced cardio-metabolic risks and future cardiovascular events. Sodium-glucose co-transporter-2 (SGLT2) inhibitors reduce body fat including ...
Known for Type 2 | Epicardial Fat | Luseogliflozin Treatment | Vfa Lai
KOL-Index: 11052 . The purpose of this study was to examine whether periodontal treatment incorporating topical antibiotic therapy affects on levels of glycohemoglobin (HbA1c) and serum high-sensitivity C-reactive protein (hs-CRP) in type 2 diabetic patients with periodontal disease, and to explore the relationship between CRP and glycemic control. The whole intervention group (n=32), which underwent ...
Known for Periodontal Treatment | Type 2 | Diabetic Patients | Reduction Hba1c
KOL-Index: 10659 . BACKGROUND: Whole body dual-energy X-ray absorptiometry (DXA) can simultaneously measure both regional fat and non-fat mass. Android-to-gynoid (A/G) ratio measured by DXA has been reported to be associated with cardiovascular risks and visceral adiposity; however, little is known regarding its relationship with fatty liver disease and atherosclerosis among patients with diabetes. This ...
Known for Type 2 | Fatty Liver | Fat Mass | Ray Absorptiometry
KOL-Index: 10547 . OBJECTIVE: Among indirect measures of visceral adiposity, A Body Shape Index (ABSI), which is defined as waist circumference (WC)/(body mass index (BMI)(2/3)×height(1/2)), is unique in that ABSI is positively correlated with visceral adiposity and is supposed to be independent of BMI. ABSI has been also shown to be linearly and positively associated with visceral fat mass and all-cause and ...
Known for Arterial Stiffness | Visceral Adiposity | Type 2 Diabetes | Bmi Absi
KOL-Index: 10203 . Sarcopenia is defined as an age-related loss of skeletal muscle mass and strength, and is a major cause of disability and mobility limitations. Recent studies have demonstrated that type 2 diabetes and insulin signaling deficiencies contribute to the progression of sarcopenia, suggesting that a sufficient supply of insulin to the skeletal muscles may be important for the maintenance of ...
Known for Insulin Treatment | Type 2 Diabetes | Muscle Mass | Sarcopenia Patients
KOL-Index: 9603 . Liraglutide, an analogue of human glucagon-like peptide 1, reduces cardiovascular events in patients with type 2 diabetes; however, it has still been unknown by which mechanisms liraglutide could reduce cardiovascular events. Type 2 diabetic patients with insulin treatment were enrolled in this randomized, open-label, comparative study. Participants were randomly assigned to liraglutide ...
Known for Type 2 | Visceral Fat | Hepatic Steatosis | Liraglutide Treatment
KOL-Index: 9466 . AIMS/INTRODUCTION: To investigate whether the ratio of visceral fat area (VFA) to subcutaneous fat area (SFA; V/S ratio) could be predictive of cardiovascular disease (CVD) as compared with VFA or SFA in patients with diabetes. MATERIALS AND METHODS: A total of 682 patients with type 2 diabetes (mean age 64 ± 13 years; 41% women) were enrolled. VFA (cm2 ) and SFA (cm2 ) were assessed by a ...
Known for Type 2 Diabetes | Vfa Sfa | Subcutaneous Fat | Cardiovascular Events
KOL-Index: 9195 . AIM: Endothelial dysfunction is considered an early event in the development of atherosclerosis. The present study was undertaken to determine whether the accumulation of cardiovascular risk factors and insulin resistance are associated with endothelial function in diabetic patients. METHODS: 101 patients with type 2 diabetes without macroangiopathy stratified by the number of ...
Known for Insulin Resistance | Endothelial Dysfunction | Diabetic Patients | Type 2 Endothelium
KOL-Index: 8868 . Measurement of late-night and/or midnight salivary cortisol currently used in US and European countries is a simple and convenient screening test for the initial diagnosis of Cushing's syndrome (CS). Unfortunately, this test has not been widely used in Japan. The purpose of this study was to evaluate the usefulness of the measurement of late-night salivary cortisol as a screening test for ...
Known for Salivary Cortisol | Screening Test | Normal Subjects | Cushings Syndrome
KOL-Index: 8734 . OBJECTIVES: Chronic inflammation of periodontitis aggravates glycemic control in type 2 diabetic patients through aggravation of insulin resistance. Increased or decreased release of various inflammatory mediators, such as high sensitivity C-reactive protein (hs-CRP), tumor necrosis factor (TNF)-α, interleukin (IL)-6 and adipokines, such as adiponectin, leptin, and resistin, are presumed ...
Known for Periodontal Treatment | Glycemic Control | Type 2 | Insulin Resistance
KOL-Index: 8733 . A 75-year-old woman was admitted to our hospital because of a poor glycemic control. She was found to have Cushingoid feature and dynamic endocrine tests showed elevated plasma ACTH and cortisol levels, lack of their circadian rhythm, non-suppressibility to high-dose dexamethasone, responsiveness to CRH, but not to DDAVP, and suppression to octreotide. Pituitary MRI showed an equivocal ...
Known for Ectopic Acth Syndrome | Carcinoid Tumor | Cushing Disease | Fluorodeoxyglucose F18
KOL-Index: 8006 . Primary aldosteronism (PA), an autonomous aldosterone hypersecretion from adrenal adenoma and/or hyperplasia, and subclinical Cushing syndrome (SCS), a mild but autonomous cortisol hypersecretion from adrenal adenoma without signs or symptoms of Cuhing's syndrome, are now well-recognized clinical entities of adrenal incidentaloma. However, the clinicopathological features of PA associated ...
Known for Pa Scs | Primary Aldosteronism | Adrenal Adenoma | Subclinical Cushing
KOL-Index: 7880 . Flow-mediated vasodilatation (FMD) is a vascular functional test to detect endothelial dysfunction at the early stage of cardiovascular diseases. Patients with active acromegaly have higher morbidity and mortality due to cardiovascular events. To determine whether active acromegaly is associated with endothelial dysfunction, we studied 17 patients with active acromegaly for measurements of ...
Known for Endothelial Dysfunction | Active Acromegaly | Fmd Patients | Insulin Growth

Key People For Type 2 Diabetes

Top KOLs in the world
#1
David Richard Matthews
type 2 diabetes sri lanka growth hormone
#2
Frank B Hu
type 2 diabetes cardiovascular disease physical activity
#3
Rury R Holman
type 2 diabetes cardiovascular disease impaired glucose tolerance
#4
David Matthew Nathan
type 2 diabetes insulin resistance cardiovascular disease
#5
John B Buse
type 2 diabetes insulin degludec cardiovascular outcomes
#6
Tuomilehto Tuomilehto
type 2 diabetes blood pressure north karelia

Center for Medical Welfare and Liaison Services, Tokyo Medical and Dental University, Bunkyo-ku, Tokyo 113-8510, Japan. | Department of Molecular Endocrinology and Metabolism, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental U